BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4037598)

  • 21. [Evaluations of vision recovery after removal of pituitary adenomas via the transsphenoidal approach].
    Scarda G; Parziale G; Gualandi C; Peroni L; Vitale L
    Riv Neurol; 1983; 53(3):200-11. PubMed ID: 6622936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scanning laser polarimetry with enhanced corneal compensation for detection of axonal loss in band atrophy of the optic nerve.
    Monteiro ML; Moura FC; Medeiros FA
    Am J Ophthalmol; 2008 Apr; 145(4):747-754. PubMed ID: 18241832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy.
    Zhang F; Chen J; Lu Y; Ding X
    J Clin Neurosci; 2009 Oct; 16(10):1273-5. PubMed ID: 19577475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transsphenoidal Microneurosurgery. Part 4: Neuroophthalmological cure in pituitary adenoma].
    Oi S; Ciric IS
    No Shinkei Geka; 1982 Nov; 10(11):1183-7. PubMed ID: 7155292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ocular symptoms in pituitary adenomas (author's transl)].
    Gajdos-Preuss A; Schaison M; Fontaine M
    J Fr Ophtalmol; 1978; 1(6-7):427-38. PubMed ID: 151702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
    Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
    AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgical treatment for giant pituitary adenomas: the state of visual functions].
    Kadashev BA; Faĭzullaev RB; Kalinin PL; Kutin MA; Shkarubo AN; Alekseev SN; Fomichev DV; Grigor'eva NN; Tropinskaia OF
    Vestn Oftalmol; 2009; 125(2):7-10. PubMed ID: 19517822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual cause of visual symptoms after bilateral laser in situ keratomileusis.
    Papalkar D; Francis IC
    J Cataract Refract Surg; 2006 Feb; 32(2):187; author reply 187. PubMed ID: 16564972
    [No Abstract]   [Full Text] [Related]  

  • 30. Why fatheads just don't see.
    Kosmorsky GS; Straga JM
    J Neuroophthalmol; 1997 Jun; 17(2):124-6. PubMed ID: 9176784
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of pituitary tumours with involvement of the visual pathways.
    Symon L; Jakubowksi J; Kamiya K
    Zentralbl Neurochir; 1981; 42(2-3):55-66. PubMed ID: 7269891
    [No Abstract]   [Full Text] [Related]  

  • 32. Atrophy of optic nerve fibres in compression of the chiasm. Prognostic implications.
    Lundström M; Frisén L
    Acta Ophthalmol (Copenh); 1977 Apr; 55(2):208-16. PubMed ID: 577092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography.
    Jacob M; Raverot G; Jouanneau E; Borson-Chazot F; Perrin G; Rabilloud M; Tilikete C; Bernard M; Vighetto A
    Am J Ophthalmol; 2009 Jan; 147(1):64-70.e2. PubMed ID: 18774545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing peripapillary atrophy is associated with progressive glaucoma.
    Uchida H; Ugurlu S; Caprioli J
    Ophthalmology; 1998 Aug; 105(8):1541-5. PubMed ID: 9709771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the visual field induced by intrasellar implantation of 90Y in 104 acromegalic patients and their subsequent course].
    Liuzzi L; Dossi F
    Arch Sci Med (Torino); 1972; 129(4):252-72. PubMed ID: 17340698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
    Mejico LJ; Miller NR; Dong LM
    Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The neuro-ophthalmological symptom complex in the clinical picture of craniopharyngiomas (the pre- and postoperative periods)].
    Serova NK; Vladimirova NA; Krasnova TS
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (1):7-11. PubMed ID: 8036863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery.
    Marcus M; Vitale S; Calvert PC; Miller NR
    Aust N Z J Ophthalmol; 1991 May; 19(2):111-8. PubMed ID: 1930993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual scotomas after transsphenoidal surgery of a pituitary macroadenoma.
    Dollfus H; Gomberg S; Touraine P; Orssaud C; Hamdani M; Derome P; Kuttenn F; Dufier JL
    J Neuroophthalmol; 1997 Sep; 17(3):204-6. PubMed ID: 9304537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Papiledema and optic atophy (author's transl)].
    Uemura Y
    No Shinkei Geka; 1977 Nov; 5(12):1225-30. PubMed ID: 593515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.